DDT Mouse

D-Dopachrome Tautomerase Mouse Recombinant
Shipped with Ice Packs
In Stock

Description

Definition and Research Context

DDT Mouse refers to experimental studies using murine models to investigate the biological impacts of DDT exposure. These studies focus on:

  • Acute and chronic toxicity

  • Metabolic disruption

  • Carcinogenic potential

  • Multigenerational effects

Perinatal Exposure Models

  • Protocol: 1.7 mg DDT/kg body weight administered daily to pregnant C57BL/6J mice from gestation day 11.5 to postnatal day 5 .

  • Findings:

    • Female offspring: Persistent thermogenic dysfunction, reduced sympathetic innervation of brown adipose tissue (BAT), and impaired glucose tolerance .

    • Male offspring: No significant metabolic changes observed .

Acute Exposure Models

  • Protocol: Single dose of p,p'-DDT (50 mg/kg) administered to female BalBc mice .

  • Findings:

    • Hepatic transcriptional changes (e.g., upregulated Cyp2b10, Ahr) without histopathological damage .

    • Impaired glucose homeostasis pathways, suggesting early biomarkers for metabolic disease .

Energy Metabolism Disruption

ParameterDDT-Exposed MiceControl MiceSource
BAT Sympathetic Axons20% reductionNormal
Norepinephrine (BAT)No changeNormal
Glucose IntoleranceSignificantNormal
  • Mechanism: DDT reduces synaptic connectivity in stellate ganglia by 43–48%, impairing sympathetic regulation of BAT .

Hepatic Effects

  • Gene Expression: Acute DDT exposure upregulated Cyp2b10 (x14.3), Ahr (x3.2), and Nqo1 (x2.1), indicating oxidative stress response .

  • Histopathology: No visible liver damage despite transcriptional changes .

Endocrine and Reproductive Impacts

  • Delayed Puberty: Vaginal opening delayed by 2–3 days in female offspring .

  • Adipose Tissue Retention: DDT’s lipophilic nature promotes accumulation in adipose tissue, potentially exacerbating diabetic conditions .

Carcinogenic Potential

  • Hepatic Tumors:

    • DDT induced liver tumors in CF-1 mice, with metastasis to lungs .

    • Tumor incidence: 32% in high-dose groups vs. 4% in controls .

  • Controversy: Early EPA claims of human carcinogenicity were later revised due to methodological flaws .

Therapeutic Implications of DDT-Related Proteins

  • D-Dopachrome Tautomerase (D-DT):

    • Functions as a cytokine (designated MIF-2) and binds MIF receptors .

    • Survival Rates: Anti-DDT antibodies increased survival from 20% to 79% in endotoxemic mice .

Comparative Analysis of DDT Metabolites

CompoundEffect on BAT SynapsesThermoregulatory ImpactSource
p,p'-DDT20% axon lossSevere impairment
p,p'-DDENo axon lossModerate impairment

Critical Research Gaps

  • Long-term transgenerational effects of DDT exposure.

  • Species-specific differences in tumorigenicity (inconclusive rat/hamster data) .

  • Interaction between DDT and modern metabolic stressors (e.g., high-fat diets) .

Product Specs

Introduction
Dopachrome tautomerase (DDT) is an enzyme that catalyzes the conversion of D-dopachrome to 5,6-dihydroxyindole (DHI). This enzyme belongs to the carboxy-lyase family, specifically those that cleave carbon-carbon bonds. DDT shares a 33% sequence homology with macrophage migration inhibitory factor (MIF) and exhibits similar tautomerase activity. Functionally, DDT acts as a pro-inflammatory cytokine.
Description
Recombinant DDT from Mouse has been expressed in E. coli. This non-glycosylated polypeptide consists of 141 amino acids (residues 1-118), resulting in a molecular weight of 15.5 kDa. A 23-amino acid His-tag is fused to the N-terminus of the protein. Purification is achieved through proprietary chromatographic methods.
Physical Appearance
Clear solution, sterile filtered.
Formulation
The DDT protein solution is supplied at a concentration of 1 mg/ml and contains 20 mM Tris-Hcl buffer (pH 8.0) and 10% glycerol.
Stability
For short-term storage (up to 2-4 weeks), the product can be stored at 4°C. For extended storage, it is recommended to freeze the product at -20°C. To ensure stability during long-term storage, adding a carrier protein (0.1% HSA or BSA) is advised. Repeated freeze-thaw cycles should be avoided.
Purity
The purity is determined to be greater than 95.0% using SDS-PAGE analysis.
Synonyms

D-dopachrome decarboxylase (EC:4.1.1.84), D-dopachrome tautomerase, Ddt.

Source
Escherichia Coli.
Amino Acid Sequence

MGSSHHHHHH SSGLVPRGSH MGSMPFVELE TNLPASRIPA GLENRLCAAT ATILDKPEDR VSVTIRPGMT LLMNKSTEPC AHLLVSSIGV VGTAEQNRTH SASFFKFLTE ELSLDQDRIV IRFFPLEAWQ IGKKGTVMTF L

Q&A

What concentrations of DDT are typically used in mouse studies?

Mouse studies commonly employ DDT concentrations ranging from 200-300 parts per million (ppm) in feed for adult exposure studies. These concentrations have been established to produce observable physiological and behavioral effects while allowing for sufficient survival to study reproductive outcomes. Research has shown that mice can tolerate these levels with variable responses - some individuals tolerate exposure well while others experience acute toxicity shortly after feeding begins .

For studies examining developmental exposure, concentrations may be lower but timed during critical developmental windows. For instance, perinatal exposure studies typically administer DDT during gestation and early postnatal development to assess long-term metabolic effects .

When designing DDT mouse studies, researchers should consider:

  • The specific research question (acute toxicity vs. chronic effects)

  • The mouse strain's known sensitivity to DDT (C57BL/6J mice have been well-studied)

  • The exposure route and duration that best mimics environmental or historical human exposure

  • Prior literature establishing dose-response relationships for the endpoints of interest

What are the standard protocols for administering DDT to laboratory mice?

Several administration methods have been documented in the literature:

  • Dietary incorporation: The most common method involves mixing DDT directly into standard rodent feed (such as chick starter mash) at concentrations ranging from 200-300 ppm. This approach allows for consistent daily exposure that mimics environmental contamination patterns .

  • Intraperitoneal injection: Some earlier studies dissolved DDT in sesame oil for intraperitoneal injection, which delivers a precise dose but creates a different exposure pattern than dietary administration .

  • Perinatal exposure protocol: For developmental studies, dams are typically exposed during pregnancy and lactation. For example, one protocol administered DDT to mice from gestational day 11.5 to postnatal day 5, followed by litter culling to 6 pups to normalize lactational transfer of DDT and maternal behavior effects .

When selecting an administration method, researchers should consider:

  • The relevance to human exposure routes

  • Consistency in dosing

  • Potential confounding effects of the vehicle

  • The specific physiological system being investigated

How should researchers standardize litter size in reproductive DDT studies?

Standardization of litter size is crucial in studies examining perinatal DDT exposure to minimize confounding variables. Based on published protocols:

  • Cull litters to a standard number of pups (e.g., 6 pups per litter) after the final DDT dose (e.g., on PND 5) .

  • This standardization serves multiple purposes:

    • Minimizes infanticide common among certain mouse strains (e.g., C57BL/6J)

    • Normalizes lactational transfer of DDT

    • Controls for maternal behavior effects that might vary with litter size

    • Ensures comparable nutrition among pups during the critical developmental period

  • When weaning pups (typically at PND 21), house them according to sex/litter/treatment to maintain experimental control .

This methodological approach is essential for isolating the direct effects of DDT exposure from secondary effects related to maternal care or nutrition.

How does DDT exposure affect mouse reproduction and what methods best assess these effects?

DDT exposure affects mouse reproduction through multiple pathways that require systematic assessment. Research has demonstrated that while conception rates may remain similar between DDT-exposed and control mice, reproductive success is significantly compromised .

Key reproductive endpoints and assessment methods include:

  • Pregnancy outcomes:

    • Monitor female survival during gestation (significantly higher mortality has been observed in DDT-exposed pregnant females)

    • Document the number of young born per female (litter size)

    • Track offspring survival rates (significantly lower in DDT-exposed groups)

  • Developmental markers:

    • Monitor timing of puberty through daily examination of vaginal opening (females) and preputial separation (males) beginning at PND 18

    • Assess body composition and growth trajectories through adulthood

  • Reproductive organ assessment:

    • Conduct gross and histological examination of reproductive organs

    • Measure and compare weights of ovaries, testes, and related organs between exposed and control animals

    • Examine for abnormalities in reproductive tissue morphology

What physiological changes occur in reproductive organs of DDT-exposed mice?

Studies examining the histology and physiology of reproductive organs in DDT-exposed mice have documented several changes:

  • Changes in reproductive organ weights:

    • Ovaries of females exposed to DDT (200-300 ppm) decreased in weight compared to controls

    • Testes of DDT-exposed males showed decreased weight

  • Adrenal gland effects:

    • Both male and female mice exposed to DDT exhibited increased adrenal gland weights

    • Statistical analysis using two-sided t-tests confirmed significant differences between mean adrenal weights of control versus DDT-treated males at both 200 and 300 ppm exposure levels

  • Relationship to reproductive outcomes:

    • These changes in reproductive organ weights correlated with impaired reproductive success

    • The physiological stress indicated by adrenal hypertrophy may contribute to reproductive impairment

Interestingly, gross histological examination of reproductive tissues often appears normal despite functional impairment, suggesting that subtle cellular or molecular changes might be responsible for the reproductive effects .

How does perinatal DDT exposure affect energy metabolism in mice?

Perinatal DDT exposure has been shown to cause significant disruptions to energy metabolism that persist into adulthood. Key findings include:

  • Thermoregulation impairment:

    • Reduced core body temperature

    • Impaired cold tolerance

    • Decreased energy expenditure

  • Metabolic programming effects:

    • Transient early-life increases in body weight

    • Long-term alterations in metabolic parameters

    • Changes in glucose tolerance persisting up to 6 months of age

  • Sex-specific differences:

    • Male and female mice often exhibit different susceptibilities to metabolic disruption

    • Hormone-dependent effects may explain some sex-specific responses

These findings suggest that DDT exposure during critical developmental windows permanently alters metabolic programming, potentially through endocrine-disrupting mechanisms. Research protocols typically assess these effects through comprehensive metabolic phenotyping including indirect calorimetry, glucose tolerance testing, and body composition analysis .

What is known about the variable tolerance to DDT in laboratory mice?

The variable tolerance to DDT observed in laboratory mice presents an important research consideration. Studies have documented substantial individual variation in DDT susceptibility, with important implications for experimental design:

  • Observed variability in acute toxicity:

    • Some mice tolerate DDT feeding quite well

    • Others die shortly after feeding begins

    • Some survive for extended periods despite continuous exposure

  • Sex differences in DDT tolerance:

    • Female mice typically show earlier onset of DDT toxicity symptoms

    • In studies with 200 ppm DDT exposure, females showed tremors on average by day 20 of exposure

    • Males typically didn't exhibit tremors until around day 41 of exposure

  • Time course of toxicity:

    • The period between first signs of tremors and death is typically short (often less than 5 hours)

    • This rapid progression from symptom onset to death suggests acute neurological toxicity mechanisms

This variability necessitates larger sample sizes and careful monitoring protocols in DDT studies. Researchers should document individual responses rather than relying solely on group averages, as the distribution of effects may be bimodal rather than normal.

What histopathological changes occur in non-reproductive organs of DDT-exposed mice?

Beyond reproductive effects, DDT exposure causes distinctive histopathological changes in several organ systems:

  • Gastrointestinal effects:

    • Hemorrhage in the gastrointestinal tract is commonly observed in mice that die from DDT toxicity

    • At 200 ppm exposure, nearly all mice examined post-mortem showed GI hemorrhage

    • At 300 ppm exposure, results were more variable, with some animals showing no GI hemorrhage

  • Renal effects:

    • Kidney weights decreased in both male and female mice exposed to DDT

    • This suggests potential impacts on renal function, though gross histological changes may not be apparent

  • Behavioral signs preceding mortality:

    • Hyperactivity and tremors are characteristic signs of acute DDT toxicity

    • These neurological symptoms typically precede death by only a few hours

    • Starvation stress dramatically accelerates DDT toxicity in previously tolerant mice

These findings highlight the importance of comprehensive tissue examination in DDT studies, even when the primary research focus is on reproduction or metabolism.

How should researchers account for maternal effects when studying offspring responses to DDT?

When designing studies examining developmental DDT exposure, controlling for maternal effects is essential:

  • Standardized protocols to minimize maternal confounds:

    • Normalize litter size through culling (typically to 6 pups/litter)

    • Monitor maternal behavior and health throughout the lactation period

    • Control for potential differences in maternal care that might result from DDT-induced behavioral changes

  • Statistical approaches:

    • Use litter as the unit of analysis rather than individual pups to account for within-litter correlation

    • Include maternal weight, food consumption, and behavior as covariates in statistical models

    • Consider using mixed-effects models that can account for nested data structures (pups within litters)

  • Experimental controls:

    • Cross-fostering designs can help separate prenatal from postnatal exposure effects

    • Careful monitoring of DDT transfer through milk can quantify postnatal exposure

These approaches help distinguish direct developmental toxicity of DDT from indirect effects mediated through maternal physiology or behavior.

What are the methodological challenges in assessing long-term metabolic effects of DDT exposure?

Researchers face several methodological challenges when investigating long-term metabolic consequences of DDT exposure:

  • Study duration requirements:

    • Metabolic effects may not manifest until adulthood or middle age

    • Studies must extend at least 6 months to capture persistent metabolic programming effects

    • This extended timeline increases costs and complexity

  • Comprehensive phenotyping needs:

    • Multiple metabolic parameters must be assessed: body composition, energy expenditure, glucose tolerance, cold tolerance, etc.

    • Specialized equipment for indirect calorimetry and body composition analysis is required

    • Standardized challenge tests (glucose tolerance, cold exposure) must be systematically applied

  • Intervention studies:

    • Testing metabolic resilience requires additional experimental arms

    • High-fat diet challenges are often employed to reveal latent metabolic dysfunction

    • These challenges require randomization of subjects into additional study arms

These challenges necessitate careful advance planning and sufficient resources to capture the full spectrum of potential metabolic impacts.

How can researchers analyze variable survival rates in DDT exposure studies?

The variable mortality observed in DDT-exposed mice presents analytical challenges requiring specialized approaches:

  • Survival analysis techniques:

    • Kaplan-Meier survival curves should be employed rather than simple mortality percentages

    • Cox proportional hazards models can identify factors associated with mortality risk

    • These approaches account for variable follow-up times and censored observations

  • Accounting for survivor bias:

    • Mice surviving chronic DDT exposure may represent a selected subpopulation with greater innate tolerance

    • Analyses of effects in survivors should acknowledge this potential selection bias

    • When possible, physiological parameters should be assessed in all animals prior to onset of mortality

  • Documenting patterns of mortality:

    • Time from exposure initiation to first symptoms

    • Time from first symptoms to death

    • Sex-specific mortality patterns (females typically show earlier effects)

    • Potential correlation between mortality and reproductive status

These approaches provide more nuanced understanding of DDT toxicity dynamics than simple LD50 determinations.

What are the critical knowledge gaps in understanding DDT effects in mouse models?

Despite extensive research, important knowledge gaps remain in understanding DDT's effects in mouse models:

These knowledge gaps present opportunities for researchers to make significant contributions to understanding DDT toxicity mechanisms.

What methodological improvements would advance DDT mouse research?

Several methodological advances could significantly enhance the quality and relevance of DDT mouse research:

  • Improved exposure assessment:

    • More sensitive analytical methods for measuring tissue DDT and metabolite concentrations

    • Better understanding of the relationship between administered dose and internal exposure

    • More realistic exposure scenarios mimicking environmental patterns

  • Molecular and 'omics approaches:

    • Integration of transcriptomics, metabolomics, and epigenomics to identify mechanisms

    • Application of single-cell approaches to identify cell-specific responses

    • Systems biology methods to integrate multiple levels of biological effects

  • Translational approaches:

    • Better alignment of mouse endpoints with human health outcomes of concern

    • Development of biomarkers that can be applied across species

    • Integration of in vitro and in silico approaches to reduce animal use

These methodological advances would help address existing knowledge gaps and improve the human relevance of findings from mouse models.

Product Science Overview

Introduction

D-Dopachrome Tautomerase (D-DT), also known as D-dopachrome decarboxylase, is an enzyme that plays a significant role in various biological processes. It is a protein-coding gene found in mice and is homologous to the human DDT gene. This enzyme is involved in the tautomerization of D-dopachrome to 5,6-dihydroxyindole (DHI), a key step in the melanin biosynthesis pathway.

Gene and Protein Structure

The Ddt gene is located on chromosome 10 in mice, specifically at the position 75607067-75609208 bp on the negative strand . The gene encodes a protein that shares structural and functional similarities with the macrophage migration inhibitory factor (MIF), another important cytokine involved in immune responses .

Biological Function

D-DT is known to bind to the CD74 receptor with high affinity, leading to the activation of ERK1/2 MAP kinase and downstream proinflammatory pathways . This binding and subsequent activation play a crucial role in the immune response, particularly in the regulation of inflammation. The enzyme is also highly expressed in murine cardiomyocytes and is secreted by the heart after ischemic stress, indicating its protective role in cardiac function .

Recombinant Production

Recombinant D-DT is produced using various expression systems, including bacterial, yeast, and mammalian cells. The recombinant protein is often used in research to study its function and potential therapeutic applications. The production process involves cloning the Ddt gene into an expression vector, transforming the host cells, and purifying the expressed protein.

Clinical and Research Implications

Research has shown that D-DT levels correlate with disease severity in conditions such as sepsis and malignancy . The enzyme’s role in immune regulation and its protective effects in cardiac function make it a potential target for therapeutic interventions. Additionally, the study of recombinant D-DT helps in understanding its physiological and pathological roles, providing insights into the development of new treatments for inflammatory and cardiovascular diseases.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.